Private Equity Funds Harvard Research Lab, Paving Way for Future Models

A Turkish private equity firm has invested $39 million in a Harvard genetics and metabolism lab and plans to fund drug development through a new biotech, Enlila, potentially serving as a model for future academic research funding amid financial challenges faced by universities.